Vaxxinity Inc. (VAXX)
0.00
-0.00 (-100.00%)
At close: Jan 15, 2025, 9:30 AM
0.10
19780.00%
Pre-market Jun 20, 2024, 09:30 AM EDT
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Revenue | n/a | n/a | 66.00K | 557.00K | n/a |
| Cost of Revenue | 2.23M | 1.68M | 1.94M | 52.00K | 107.00K |
| Gross Profit | -2.23M | -1.68M | -1.87M | 505.00K | -107.00K |
| Operating Income | -58.28M | -75.98M | -125.08M | -32.28M | -13.66M |
| Interest Income | 2.09M | 1.26M | 9.00K | 1K | 435.00K |
| Pretax Income | -56.93K | -75.22M | -137.18M | -39.96M | -14.16M |
| Net Income | -56.93K | -75.21M | -138.01M | -35.38M | -14.22M |
| Selling & General & Admin | 22.39M | 28.35M | 51.83M | 12.22M | 3.00M |
| Research & Development | 33.66M | 47.63M | 71.38M | 20.57M | 10.66M |
| Other Expenses | n/a | n/a | -8.37M | -5.76M | -27.00K |
| Operating Expenses | 56.05M | 75.98M | 123.20M | 32.79M | 13.66M |
| Interest Expense | 696.00K | 514.00K | 840.00K | 1.18M | 435.00K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 58.28M | 75.98M | 125.14M | 32.84M | 13.66M |
| Income Tax | -56.93K | -12.00K | 840.00K | -4.58M | 56.00K |
| Shares Outstanding (Basic) | 126.51K | 125.94M | 125.39M | 125.45M | 125.45M |
| Shares Outstanding (Diluted) | 126.51K | 125.94M | 125.39M | 125.45M | 125.45M |
| EPS (Basic) | -0.45 | -0.6 | -1.1 | -0.28 | -0.11 |
| EPS (Diluted) | -0.45 | -0.6 | -1.1 | -0.28 | -0.11 |
| EBITDA | -56.05K | -74.30M | -135.23M | -31.57M | -13.58M |
| Depreciation & Amortization | 2.23K | 1.68M | 1.10M | 717.00K | 107.00K |